Sigrid Therapeutics launches Glucose Stabiliser in the US, an over-the-counter dietary supplement designed to control blood sugar and body weight

Stockholm, November 14, 2023. Sigrid Therapeutics today announced that the company has launched Glucose Stabiliser in the US. The product is an over-the-counter dietary supplement for blood sugar control that reduces calorie intake from fat and carbohydrates. Sigrid's strategic launch in the US market could not have come at a more opportune time, with approximately 1 in 10 Americans facing a type 2 diagnosis at a time when weight loss medications are increasing in popularity among the general population.

The dietary supplement, taken before the two largest meals of the day, is based on over 10 years of research. Sigrid's co-founder, Professor Tore Bengtsson, discovered that undesirable changes in metabolism were normalized after ingestion of modified silica particles. Silicon is 100% natural, and one of the most common elements on the planet.

Glucose Stabiliser is based on the patented SiPore® technology discovered in 2008. SiPore® has been shown to lower blood sugar, minimize gas and bloating, maintain a feeling of fullness for longer, reduce appetite and thereby contribute to weight loss. Clinical research has shown that patients with type 2 diabetes who took SiPore® had a 40% greater reduction in HbA1c and also in half the treatment time compared to Metformin, one of the most widely used drugs.

The particles, which are made up of micron-sized silica particles, exert their effect inside the stomach and are not absorbed into the bloodstream. The particles act as a molecular filter by mechanically protecting the food from the digestive enzymes. As the latter break down complex carbohydrates and fats, digestion is slowed down. With a slower digestive process, those using Glucose Stabiliser can expect to feel full longer, lose weight and achieve lower cholesterol levels while continuing to live their lives to the fullest without restrictions. Unlike many prescription diabetes medications with their long lists of side effects, Glucose Stabiliser is very well tolerated. With SiPore® technology, you get a product that is generally recognized as safe (GRAS – Generally Regarded As Safe). The classification confirms its safety for use to promote a slower digestive process and weight control without imposing restrictions on daily life.

Although its primary use in the diabetes field is Glucose Stabiliser, it is also an excellent alternative for non-diabetics who are considering trying the new and popular prescription weight loss medications but are put off by the cost and/or injections. Glucose Stabiliser is administered orally and stays in the stomach, and by working in a similar way but without the side effects associated with drugs that reach the bloodstream, it is a suitable alternative for those seeking general well-being and weight loss. It is also the perfect solution for those concerned about weight gain after stopping the new medications.

"Glucose Stabiliser is a testament to Sigrid's mission to help people optimize their metabolism in an affordable and accessible way," said Sana Alajmovic, CEO of Sigrid Therapeutics. "I have watched my father develop type 2 diabetes after struggling to control his blood sugar for a long time. Therefore, for me, it is as much a personal calling as it is a professional mission to develop innovative treatments that enable users to continue living their lives to the fullest without having to drastically change their lifestyle."